Cargando…

Relapsing Cutaneous Multiple Myeloma Responding to Immunochemotherapy: A Rare Case Report

Multiple myeloma (MM) is characterized by the neoplastic proliferation of plasma cells. The diagnosis of this disease is often suspected through a constellation of clinical signs and symptoms of hypercalcemia, renal failure, anemia, and M-spike proteins. It is the second most common hematological ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohamed, Mujtaba, Alhillan, Alsadiq, Gupta, Varsha, Nahum, Kenneth, Mushtaq, Arman, Zheng, Min, Hossain, Mohammad A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8383515/ https://www.ncbi.nlm.nih.gov/pubmed/34434296 http://dx.doi.org/10.14740/jmc3382

Ejemplares similares

Cutaneous involvement in relapsed multiple myeloma
por: Salle, Valéry, et al.
Publicado: (2022)

Concomitant Acute Hepatic Failure and Renal Failure Induced by Intravenous Amiodarone: A Case Report and Literature Review
por: Mohamed, Mujtaba, et al.
Publicado: (2020)

Multiple cutaneous lesions in multiple myeloma responding to radiotherapy
por: Rastogi, Madhup, et al.
Publicado: (2020)

Incidental Finding of Gastric Schwannoma in a Renal Failure Patient – Managed by a Minimally Invasive Procedure: Report of a Rare Case
por: Mujtaba, Mohamed A., et al.
Publicado: (2019)

Multiple Myeloma with Cutaneous Deposits as Rare Lymphoplasmacytoid Cells
por: Minni, Khushboo A, et al.
Publicado: (2015)

Multiple Myeloma Relapse as Intracranial Plasmacytoma: A Rare Presentation
por: Prakash, Amulya, et al.
Publicado: (2020)

Hyperammonemic Encephalopathy: A Rare Presentation of Relapsed Multiple Myeloma
por: Menakuru, Sasmith R., et al.
Publicado: (2023)

Cutaneous Multiple Myeloma
por: Miriyala, Leela Krishna Vamsee, et al.
Publicado: (2021)

A Rare Case of Signet Cell Carcinoma of Transverse Colon in a Young Patient With Ulcerative Colitis
por: Mohamed, Mujtaba, et al.
Publicado: (2020)

Multiple Cutaneous and Uterine Leiomyomatosis with Renal Involvement: Report of a Rare Association
por: Gupta, Gunjan, et al.
Publicado: (2018)

A Rare Case of Ixazomib-Induced Cutaneous Necrotizing Vasculitis in a Patient with Relapsed Myeloma
por: Katz, Heather, et al.
Publicado: (2019)

A Rare Case of Helicobacter pylori Infection Complicated by Henoch-Schonlein Purpura in an Adult Patient
por: Mohamed, Mujtaba, et al.
Publicado: (2020)

A rare case of multiple myeloma with intracranial extramedullary relapse: One or more myeloma clones?
por: Markovic, Uros, et al.
Publicado: (2019)

Dabigatran-Induced Acute Interstitial Nephritis: An Important Complication of Newer Oral Anticoagulation Agents
por: Patel, Swapnil, et al.
Publicado: (2018)

A rare case of bifocal, extramedullary and hyposecretory relapse of multiple myeloma
por: Minarik, Jiri, et al.
Publicado: (2021)

Pericardial relapse of multiple myeloma
por: Jamison, Lee S, et al.
Publicado: (2020)

Localized Cutaneous Mucinosis Associated with Multiple Myeloma: A Rare Presentation
por: Rather, Parvaiz Anwar, et al.
Publicado: (2014)

Cutaneous Manifestations of Multiple Myeloma
por: Behera, Binodini, et al.
Publicado: (2016)

Protective Cellular Immune Response Induction for Cutaneous Leishmaniasis by a New Immunochemotherapy Schedule
por: da Silva, Danielle A. M., et al.
Publicado: (2020)

Lenalidomide for the treatment of relapsed and refractory multiple myeloma
por: van de Donk, Niels WCJ, et al.
Publicado: (2012)

A Rare Case of Extramedullary Relapse of Multiple Myeloma Causing Bowel Obstruction
por: Bhardwaj, Prarthna V., et al.
Publicado: (2019)

Ocular Toxicity of Belantamab Mafodotin, an Oncological Perspective of Management in Relapsed and Refractory Multiple Myeloma
por: Wahab, Ahsan, et al.
Publicado: (2021)

Early MRI Predictors of Relapse in Primary Central Nervous System Lymphoma Treated with MATRix Immunochemotherapy
por: Cornell, Isabel, et al.
Publicado: (2023)

Carfilzomib for relapsed and refractory multiple myeloma
por: Groen, K, et al.
Publicado: (2019)

Treatment of relapsed and refractory multiple myeloma
por: Lee, Ji Hyun, et al.
Publicado: (2020)

Selinexor in relapsed/refractory multiple myeloma
por: Richter, Joshua, et al.
Publicado: (2020)

A Focus on Relapsed Multiple Myeloma
por: Noonan, Kimberly, et al.
Publicado: (2022)

Pleural plasmacytomas in a patient with multiple myeloma relapse
por: Al-Ataby, Harith, et al.
Publicado: (2022)

Symptomatic congenital Morgagni hernia presenting as a chest pain: a case report
por: Mohamed, Mujtaba, et al.
Publicado: (2020)

Current trends of anticancer immunochemotherapy
por: Vacchelli, Erika, et al.
Publicado: (2013)

Giant retrocrural plasmacytoma as a relapse of multiple myeloma
por: Feki, Afef, et al.
Publicado: (2022)

Relapsed/Refractory Multiple Myeloma: A Review of Available Therapies and Clinical Scenarios Encountered in Myeloma Relapse
por: Bhatt, Parva, et al.
Publicado: (2023)

Bendamustine in patients with relapsed or refractory multiple myeloma
por: Michael, M, et al.
Publicado: (2010)

Multiple myeloma with central nervous system relapse
por: Egan, Philip A., et al.
Publicado: (2020)

The role of carfilzomib in relapsed/refractory multiple myeloma
por: Yee, Andrew J.
Publicado: (2021)

Exceptional Responder to Immunotherapy: A Rare Case of Post-HSCT DLBCL Relapse Responding to Nivolumab
por: Madabhavi, Irappa, et al.
Publicado: (2019)

Trial Watch: Lenalidomide-based immunochemotherapy
por: Semeraro, Michaela, et al.
Publicado: (2013)

Immunochemotherapy for Richter syndrome: current insights
por: Puła, Bartosz, et al.
Publicado: (2019)

Immunotherapy and immunochemotherapy in combating visceral leishmaniasis
por: Yadagiri, Ganesh, et al.
Publicado: (2023)

Bifidobacterium in anticancer immunochemotherapy: friend or foe?
por: Procaccianti, Giorgia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fls1lru29ruhkk0m2bburlnkc5